The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study.
 
Li-Tzong Chen
Research Funding - Merck Serono (Inst); Merrimack; Novartis; Sanofi (Inst); Taiho Pharmaceutical (Inst); TTY Biopharm (Inst)
 
Long-Bin Jeng
No Relationships to Disclose
 
Chin-Fu Hsiao
No Relationships to Disclose
 
Cheng-Chung Wu
No Relationships to Disclose
 
Wei-Chen Lee
No Relationships to Disclose
 
Tsang-En Wang
No Relationships to Disclose
 
Po-Huang Lee
No Relationships to Disclose
 
Chao-Long Chen
No Relationships to Disclose
 
I-Su Chen
No Relationships to Disclose
 
King-Teh Lee
No Relationships to Disclose
 
Chung-Bao Hsieh
No Relationships to Disclose
 
Wei-Shou Hwang
No Relationships to Disclose
 
Mei-Due Yang
No Relationships to Disclose
 
Yang-Sen Yang
No Relationships to Disclose
 
Deng-Yn Lin
No Relationships to Disclose
 
Miin-Fu Chen
No Relationships to Disclose
 
Pei-Jer Chen
Research Funding - Medigene